We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.

Best translational publication in the field of DPLD

Former CPC-M physician Dr. Kai Förster receives award for his research on premature babies
Dr. Kai Förster

Dr. Kai Förster - Foto © Dietmar Lauffer

 

Two prizes were awarded at the DPLD Annual Meeting in Heidelberg in June 2018: The best basic scientific and the best translational publication of the disease area DPLD (Diffuse Pulmonary Parenchyma Diseases). A team of independent international reviewers evaluated all original papers from 2017.

The prize-winning publication by Dr. Kai Förster describes the early diagnosis of chronic lung diseases in premature babies. It focuses on three specific marker proteins that can be detected in the blood of premature infants shortly after birth. This new diagnostic possibility could enable a faster and more individual therapy of chronic lung diseases in premature babies.

A detailed report on the project and a link to the study can be found here.

Dr. Kai Martin Förster is a neonatologist and was a member - until end of 2018 - of the research group led by Dr. Anne Hilgendorff, which is investigating "Mechanisms of Neonatal Chronic Lung Disease" at the CPC-M.
 

 

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:

Show detail settings
Please find more information in our privacy statement.

There you may also change your settings later.